ReCell Skin Spray
In cell spray technology, a suitable cell suspension is created from a thin split-thickness skin biopsy using a single-use, stand-alone autologous cell harvesting kit. Along with the undifferentiated basal cells it collects at the epidermal-dermal junction, it also provides melanocytes, Langerhans cells, fibroblasts and keratinocytes. The cell suspension is ready for use in only 30 minutes and covers an area up to 80 times the size of the biopsy. By achieving rapid epithelialisation, the delivered cell suspension enables the patient’s own tissue cells to redevelop natural tissue, vascularisation and pigment, usually within 5 to 7 days of the biopsy.
Cell spray is an innovative device and application used across a wide range of indications for the treatment of wounds, burns, scars and skin disorders.
Cell spray technology harnesses the regenerative capacity of the skin. Working with a small sample taken from the patient’s own skin, it produces a suspension containing the cells needed for healthy skin development. Prepared from different types of healthy cells, the cell suspension is sprayed onto the area to be treated, and this mixture contains the cells required for skin structure (fibroblasts), vascularisation (colour), pigmentation (melanocytes) and tissue formation.
Cell Suspension Composition
The cells collected from the dermal-epidermal junction contain:
- Keratinocytes
- Melanocytes
- Fibroblasts
- Langerhans cells
- Undifferentiated basal cells
- Not yet fully differentiated
- Highly Proliferative
- Cultured in situ
- Even migration across the wound
- Rich signalling matrix
- Approximately 2.8 million viable cells from a 2 cm² biopsy